Zirabev – Bevacizumab uses, dose and side effects
Zirabev contains the active ingredient bevacizumab, which is a humanized monoclonal antibody (a type of protein normally made by the immune system to help protect the body against infection and cancer). Bevacizumab binds selectively to a protein called VEGF ( human vascular endothelial growth factor), which is found inside the body’s blood and lymph vessels. The VEGF protein causes blood vessels to grow in the tumor and these blood vessels supply the tumor with nutrients and oxygen. When bevacizumab is bound to VEGF, it prevents tumor growth by blocking the growth of the blood vessels that supplytumor one with nutrients and oxygen.
Read More